We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Freeline

News List

Freeline Announces Executive Leadership Changes firstwordpharma
July 01, 2021
FRLN today announced the expansion of its executive leadership team with the appointment of James "Jay" Bircher as Chief Technical Operations Officer effective July 1, 2021.
Freeline modifies clinical development plan for Hemophilia B programme pharmaceutical-technology
February 10, 2021
Clinical-stage biotechnology company Freeline Therapeutics has announced a modification to the clinical development plan for its FLT180a programme for Hemophilia B.
Syncona invests $80m in Freeline’s systemic disease gene therapies pharmaceutical-technology
December 23, 2019
Syncona has committed to investing $80m in gene therapy-focused Freeline’s Series C financing round.